HIGHLIGHTS
- who: Jin Ho Choi from the Cheng Kung University Hospital, Taiwan have published the Article: Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX, in the Journal: IPMN associated invasive carcinoma
- what: A basic research with 10 patient-derived PC organoids reported results in line with the overall observations in this study that the resistance to oxaliplatin and irinotecan was developed in organoids from patients who received neoadjuvant FOLFIRINOX, proportional hazards analysis, along with negative RM, negative LN involvement for prolonged RFS and OS. The study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.